IPO Databook: Propanc Biopharma (PPCB US) - Oct 2026
Propanc Biopharma, Inc. is a development-stage healthcare company focused on developing new cancer treatments for pancreatic, ovarian, and...
126 Views
Propanc Biopharma (PPCB US): Synthetic Expert Call Transcript (19 Jul 2026)
Severe Insolvency and Going Concern Risks: Propanc Biopharma's financial position is extremely precarious, characterized by an accumulated...
87 Views
No more insights